The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Brain region‐specific deficit in mitochondrial electron transport chain complexes in children with autism
Open accessAbstract
J. Neurochem. (2011) 117, 209–220. Mitochondria play important roles in generation of free radicals, ATP formation, and in apoptosis. We studied the levels of mitochondrial electron transport chain (ETC) complexes, that is, complexes I, II, III, IV, and V, in brain tissue samples from the cerebellum and the frontal, parietal, occipital, and temporal cortices of subjects with autism and age‐matched control subjects. The subjects were divided into two groups according to their ages: Group A (children, ages 4–10 years) and Group B (adults, ages 14–39 years). In Group A, we observed significantly lower levels of complexes III and V in the cerebellum (p < 0.05), of complex I in the frontal cortex (p < 0.05), and of complexes II (p < 0.01), III (p < 0.01), and V (p < 0.05) in the temporal cortex of children with autism as compared to age‐matched control subjects, while none of the five ETC complexes was affected in the parietal and occipital cortices in subjects with autism. In the cerebellum and temporal cortex, no overlap was observed in the levels of these ETC complexes between subjects with autism and control subjects. In the frontal cortex of Group A, a lower level of ETC complexes was observed in a subset of autism cases, that is, 60% (3/5) for complexes I, II, and V, and 40% (2/5) for complexes III and IV. A striking observation was that the levels of ETC complexes were similar in adult subjects with autism and control subjects (Group B). A significant increase in the levels of lipid hydroperoxides, an oxidative stress marker, was also observed in the cerebellum and temporal cortex in the children with autism. These results suggest that the expression of ETC complexes is decreased in the cerebellum and the frontal and temporal regions of the brain in children with autism, which may lead to abnormal energy metabolism and oxidative stress. The deficits observed in the levels of ETC complexes in children with autism may readjust to normal levels by adulthood.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the cerebellum, the levels of lipid hydroperoxide [103], a product of fatty acid oxidation; of malonyldialdehyde [104], an end-product of lipid peroxidation; of 8-hydroxy-2’-deoxyguanosine (8-OH-dG) [105, 106], a marker of oxidative DNA damage; of protein carbonyl [107], a marker of protein oxidation; and of 3-nitrotyrosine [108], a marker of protein nitration, were significantly increased in”
From Consensus Paper: Pathological Role of the Cerebellum in Autism (2012) · cites this paper as [103]
In the citing paper
“Our studies of different brain regions showed that oxidative stress differentially affects selective brain regions, i.e., cerebellum, temporal and frontal cortices, in autism [103–105, 107]. Increased oxidative stress and mitochondrial abnormalities were not observed in the parietal and occipital cortices in autism [103–105, 107].”
From Consensus Paper: Pathological Role of the Cerebellum in Autism (2012) · cites this paper as [103]
In the citing paper
“Reduced levels of complexes III and V in the cerebellum, of complex I in the frontal cortex, and of complexes II, III, and V in the temporal cortex were observed in children with autism as compared to age-matched control subjects [103].”
From Consensus Paper: Pathological Role of the Cerebellum in Autism (2012) · cites this paper as [103]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial free radical generation, oxidative stress, and aging
Cadenas, E., & Davies, K. J. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00317-8 · Cited by 3,010
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. A. D., Dexter, D. T., Jenner, P. G., Clark, J. B., & MARSDEN, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,757
Histoanatomic observations of the brain in early infantile autism
Bauman, M., & Kemper, T. L. (1985) · Neurology · doi:10.1212/wnl.35.6.866 · Cited by 964
James, S. J., Cutler, P., Melnyk, S., Jernigan, S., Janak, L., Gaylor, D. W., & Neubrander, J. A. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1611 · Cited by 955
Neuroanatomic observations of the brain in autism: a review and future directions
Bauman, M. L., & Kemper, T. L. (2005) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.09.006 · Cited by 919
Rice, C. E. (2009) · PsycEXTRA Dataset · doi:10.1037/e562722010-001 · Cited by 762
Mitochondrial defect in Huntington's disease caudate nucleus
Gu, M., Gash, M. T., Mann, V. M., Javoy‐Agid, F., Cooper, J. M., & Schapira, A. H. V. (1996) · Annals of Neurology · doi:10.1002/ana.410390317 · Cited by 758
Chauhan, A., & Chauhan, V. (2006) · Pathophysiology · doi:10.1016/j.pathophys.2006.05.007 · Cited by 656
Self-citationEnergetic basis of brain activity: implications for neuroimaging
Shulman, R. G., Rothman, D. L., Behar, K. L., & Hyder, F. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.06.005 · Cited by 590
Research works printed but not linked: 1
- Muthaiyah B., 2009, Increased lipid peroxidation in cerebellum and temporal cortex of brain in autism, J. Neurochem., 108
Cited by
Sorted by citations
Items 101–200 of 247
The BOLD signal and neurovascular coupling in autism
Reynell, C., & Harris, J. J. (2013) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2013.07.003 · Cited by 41
Giulivi, C., Napoli, E., Schwartzer, J. J., Careaga, M., & Ashwood, P. (2013) · Mediators of Inflammation · doi:10.1155/2013/609602 · Cited by 36
Blaylock, R. L., Strunecká, A., Patočka, J., & Strunecký, O. (2018) · Surgical Neurology International · doi:10.4103/sni.sni_407_17 · Cited by 36
The variation game: Cracking complex genetic disorders with NGS and omics data
Cui, H., Dhroso, A., Johnson, N. T., & Korkin, D. (2015) · Methods · doi:10.1016/j.ymeth.2015.04.018 · Cited by 36
Repurposing SGLT2 Inhibitors for Neurological Disorders: A Focus on the Autism Spectrum Disorder
Nakhal, M. M., Aburuz, S., Sadek, B. S., & Akour, A. A. (2022) · Molecules · doi:10.3390/molecules27217174 · Cited by 33
Kato, Y., Yokokura, M., Iwabuchi, T., Murayama, C., Harada, T., Goto, T., Tamayama, T., Kameno, Y., Wakuda, T., Kuwabara, H., et al. (2022) · American Journal of Psychiatry · doi:10.1176/appi.ajp.22010014 · Cited by 32
El-Ansary, A. K., Bjørklund, G., Khemakhem, A. M., AL-Ayadhi, L. Y., Chirumbolo, S., & Bacha, A. G. B. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1091-5 · Cited by 31
Bilinovich, S. M., Uhl, K. L., Lewis, K., Soehnlen, X., Williams, M. R., Vogt, D. L., Prokop, J. W., & Campbell, D. B. (2020) · Developmental Neuroscience · doi:10.1159/000513536 · Cited by 31
Exploring Dietary Interventions in Autism Spectrum Disorder
Pérez-Cabral, I. D., Bernal-Mercado, A. T., Islas-Rubio, A. R., Suárez-Jiménez, G. M., Robles-García, M. Á., Puebla-Duarte, A. L., & Del‐Toro‐Sánchez, C. L. (2024) · Foods · doi:10.3390/foods13183010 · Cited by 40
El-Ansary, A. K., Hassan, W. M., Daghestani, M. H., AL-Ayadhi, L. Y., & Bacha, A. G. B. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227626 · Cited by 29
RetractedJanickova, L., Rechberger, K. F., Wey, L., & Schwaller, B. (2020) · Molecular Autism · doi:10.1186/s13229-020-00323-8 · Cited by 30
Anderson, G., & Maes, M. H. J. (2014) · Current Neuropharmacology · doi:10.2174/1570159x11666131120223757 · Cited by 31
Gu, F., Chauhan, V. P. S., & Chauhan, A. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24027 · Cited by 29
Self-citationExploring sulforaphane as neurotherapeutic: targeting Nrf2-Keap & Nf-Kb pathway crosstalk in ASD
Shah, A., Varma, M., & Bhandari, R. (2023) · Metabolic brain disease · doi:10.1007/s11011-023-01224-4 · Cited by 28
Mehra, S., Ahsan, A. U., Seth, E., & Chopra, M. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02033-7 · Cited by 28
Simon, J. M., Paranjape, S. R., Wolter, J. M., Salazar, G., & Zylka, M. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-39016-5 · Cited by 24
Oxidative stress, metabolic and mitochondrial abnormalities associated with autism spectrum disorder
Thorsen, M. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.04.018 · Cited by 26
Autism and EMF? Plausibility of a pathophysiological link part II
Herbert, M. R., & Sage, C. (2013) · Pathophysiology · doi:10.1016/j.pathophys.2013.08.002 · Cited by 28
Abdul, F., Sreenivas, N., Kommu, J. V. S., Banerjee, M., Berk, M., Maes, M. H. J., Leboyer, M., & Debnath, M. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2021-0022 · Cited by 26
Association of IMMP2L deletions with autism spectrum disorder: A trio family study and meta‐analysis
Zhang, Y., Liu, Y., Zarrei, M., Tong, W. W. L., Dong, R., Wang, Y., Zhang, H., Yang, X., MacDonald, J. R., Uddin, M. J., et al. (2017) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32608 · Cited by 26
Mitochondrial respiratory chain defects in autism and other neurodevelopmental disorders
Chauhan, A., Gu, F., & Chauhan, V. P. S. (2016) · Journal of Pediatric Biochemistry · doi:10.1055/s-0036-1586418 · Cited by 25
Self-citationKumar, M., Mehan, S., Kumar, A., Sharma, T., Khan, Z., Tiwari, A., Gupta, G. D., & Narula, A. S. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149251 · Cited by 26
Almulla, A. F., Thipakorn, Y., Tunvirachaisakul, C., & Maes, M. H. J. (2023) · Autism Research · doi:10.1002/aur.3044 · Cited by 24
Mitochondrial bioenergetics and disease in Caenorhabditis elegans
Rabbitts, B. M. (2015) · Frontiers in bioscience · doi:10.2741/4305 · Cited by 26
Zhang, S., Zhou, Y., Shen, J., Wang, Y., Xia, J., Li, C., Liu, W., Hayat, K., & Qian, M. (2024) · Environmental Science & Technology · doi:10.1021/acs.est.4c04760 · Cited by 21
Shen, L., Zhang, H., Jing, L., Gao, Y. L., Liu, X., Chen, M., Khan, N. U., Tang, X., Hong, Q., Feng, C., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02801-x · Cited by 23
Hassan, H., Zakaria, F., Makpol, S., & Karim, N. A. (2021) · Current Issues in Molecular Biology · doi:10.3390/cimb43030157 · Cited by 22
Cucinotta, F., Ricciardello, A., Turriziani, L., Mancini, A., Keller, R., Sacco, R., & Persico, A. M. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.829516 · Cited by 21
Nabi, S. U., Rehman, M. U., Arafah, A. M., Taifa, S., Khan, I. S., Khan, A., Rashid, S., Jan, F., Wani, H. A., & Ahmad, S. F. (2022) · Current Neuropharmacology · doi:10.2174/1570159x21666221121095618 · Cited by 22
Update on Atypicalities of Central Nervous System in Autism Spectrum Disorder
Shuid, A. N., Jayusman, P. A., Shuid, N., Ismail, J., Nor, N. K., & Mohamed, I. N. (2020) · Brain Sciences · doi:10.3390/brainsci10050309 · Cited by 23
Baxter, K. K., Uittenbogaard, M. N., & Chiaramello, A. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.07.004 · Cited by 20
Comparison of urinary oxidative biomarkers in Iranian children with autism
Ranjbar, A., Rashedi, V., & Rezaei, M. (2014) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2014.07.010 · Cited by 20
Suhaibani, A. A., Bacha, A. G. B., Alonazi, M. A., Bhat, R. S., & El-Ansary, A. K. (2021) · Food Science & Nutrition · doi:10.1002/fsn3.2418 · Cited by 19
Efe, A., Neşeli̇oğlu, S., & Soykan, A. A. (2020) · Autism Research · doi:10.1002/aur.2436 · Cited by 18
Esvap, E., & Ülgen, K. Ö. (2023) · Biomedicines · doi:10.3390/biomedicines11020583 · Cited by 20
Metabolomic biomarkers in autism: identification of complex dysregulations of cellular bioenergetics
Smith, A. M., Donley, E. L. R., Ney, D. M., Amaral, D. G., Burrier, R. E., & Natowicz, M. R. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1249578 · Cited by 18
Bordt, E. A., Moya, H., Jo, Y. C., Ravichandran, C. T., Bankowski, I. M., Ceasrine, A. M., McDougle, C. J., Carlezon, W. A., & Bilbo, S. D. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.11.010 · Cited by 21
Autism, Mitochondria and Polybrominated Diphenyl Ether Exposure
Wong, S., & Giulivi, C. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666160413122624 · Cited by 18
Nitric oxide pathway as a plausible therapeutic target in autism spectrum disorders
Mehta, R., Kuhad, A., & Bhandari, R. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2100252 · Cited by 17
The need for a comprehensive molecular characterization of autism spectrum disorders
Broek, J. A. C., Brombacher, E., Stelzhammer, V., Guest, P. C., Rahmoune, H., & Bahn, S. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571300117x · Cited by 17
NLRP3 inflammasome-mitochondrion loop in autism spectrum disorder
Vallese, A., Cordone, V., Ferrara, F., Guiotto, A., Gemmo, L., Cervellati, F., Hayek, J., Pecorelli, A., & Valacchi, G. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.10.297 · Cited by 16
Chauhan, V. P. S., & Chauhan, A. (2016) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2016.04.010 · Cited by 16
Self-citationCarli, S., Chaabane, L., Butti, C., Palma, C. D., Aimar, P., Salio, C., Vignoli, A., Giustetto, M., Landsberger, N., & Frasca, A. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15300 · Cited by 17
Siena, A., Yuzawa, J. M. C., Ramos, A. C., Henrique, E., Brito, M. D., Calvazara, M. B., & Rosenstock, T. R. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02317-w · Cited by 17
Ji, L., Chauhan, A., & Chauhan, V. P. S. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4742 · Cited by 16
Self-citationTargeted Biomedical Treatment for Autism Spectrum Disorders
Pacheva, I. H., & Ivanov, I. S. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191205091312 · Cited by 17
Al-Orf, N., El-Ansary, A. K., Bjørklund, G., Moubayed, N., Bhat, R. S., & Bacha, A. G. B. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0284-5 · Cited by 15
Cieślik, M., Zawadzka, A., Czapski, G. A., Wilkaniec, A., & Adamczyk, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087243 · Cited by 15
Chronic Ambient Ozone Exposure Aggravates Autism-Like Symptoms in a Susceptible Mouse Model
Ling, W., Ren, Z., Wang, W., Lü, D., Zhou, Q., Liu, Q. S., & Jiang, G. (2023) · Environmental Science & Technology · doi:10.1021/acs.est.3c00607 · Cited by 14
Association of NGF and Mitochondrial Respiration with Autism Spectrum Disorder
Gevezova, M., Minchev, D. S., Pacheva, I., Todorova, T., Yordanova, R. V., Timova, E., Ivanov, I. S., & Sarafian, V. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911917 · Cited by 15
Kumar, H., Diwan, V., & Sharma, B. (2022) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2022.20.4.725 · Cited by 13
Gao, H., Ni, Y., Mo, X., Li, D., Teng, S., Huang, Q., Huang, S., Liu, G., Zhang, S., Tang, Y., et al. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.06.046 · Cited by 13
Kamalmaz, N., Bacha, A. G. B., Alonazi, M. A., Albasher, G. I., Khayyat, A. I. A., & El-Ansary, A. K. (2023) · PeerJ · doi:10.7717/peerj.15488 · Cited by 11
Schrickel, A., Groeneweg, J., & Dekeyster, E. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-024-01518-1 · Cited by 11
The Inferior Colliculus in Alcoholism and Beyond
Bordia, T., & Zahr, N. M. (2020) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2020.606345 · Cited by 12
Čorejová, A., Fazekaš, T., Jánošíková, D., Repiský, J., Pospíšilová, V., Miková, M., Rauová, D., Ostatníková, D., Kyselovič, J., & Hrabovská, A. (2022) · Nutrients · doi:10.3390/nu14102035 · Cited by 14
The complex genetics in autism spectrum disorders
Hua, R., Wei, M., & Zhang, C. (2015) · Science China Life Sciences · doi:10.1007/s11427-015-4893-5 · Cited by 11
Developmental exposure to mercury chloride does not impair social behavior of C57BL/6 × BTBR F1mice
Zhang, Y., Bolivar, V. J., & Lawrence, D. A. (2012) · Journal of Immunotoxicology · doi:10.3109/1547691x.2012.682663 · Cited by 11
Erdoğan, M. A., Türk, M., Doğanay, G. D., Sever, İ. H., Özkul, B., Söğüt, İ., Eroğlu, E., Uyanıkgil, Y., & Erbaş, O. (2023) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-023-10089-4 · Cited by 10
Sandhu, A., Rawat, K., Gautam, V., Kumar, A., Sharma, A., Bhatia, A., Grover, S., Saini, L. K., & Saha, L. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111126 · Cited by 11
Autism Spectrum Disorders: The Mitochondria Connection
Wen, Y., & Yao, Y. (2021) · Exon Publications eBooks · doi:10.36255/exonpublications.autismspectrumdisorders.2021.mitochondria · Cited by 11
Afaf, K. E. A., Bacha, A. G. B., Ghada, H. S., & Laila, Y. A. A. (2013) · African Journal of Microbiology Research · doi:10.5897/ajmr12.1178 · Cited by 10
Lima-Castañeda, L. Á., Bringas, M. E., Aguilar‐Hernández, L., Garcés‐Ramírez, L., Morales‐Medina, J. C., & Flores, G. (2023) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2023.102317 · Cited by 10
The role and impact of abnormal vitamin levels in autism spectrum disorders
Cui, J., Zhai, Z., Wang, S., Song, X., Qiu, T., Yu, L., Zhai, Q., & Zhang, H. (2024) · Food & Function · doi:10.1039/d3fo03735e · Cited by 11
Rossignol, D. A., & Frye, R. E. (2011) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-011-1276-z · Cited by 9
Çolak, H., Sarıyer, E. T., & Noğay, N. H. (2023) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10254 · Cited by 10
Seeing beyond words: Visualizing autism spectrum disorder biomarker insights
Xie, X., Zhou, R., Fang, Z., Zhang, Y., Wang, Q., & Liu, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30420 · Cited by 9
Öz, F., Kaya, İ., Tanır, Y., Küçükgergin, C., & Aydin, A. F. (2024) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.23.1153 · Cited by 7
Feron, F. P., Caillol, D., Fourel, L., Leimkühler, S., Iranzo, O., Gepner, B., & Guiraudie-Capraz, G. (2025) · Scientific Reports · doi:10.1038/s41598-025-22327-1 · Cited by 7
Vilela, J. E. R., Martiniano, H., Marques, A. R., Santos, J. X., Asif, M., Rasga, C., Oliveira, G., & Vicente, A. M. (2023) · Biomedicines · doi:10.3390/biomedicines11112971 · Cited by 7
Folate receptor alpha autoimmunity and cerebral folate deficiency in autism spectrum disorders
Rossignol, D. A., & Frye, R. E. (2016) · Journal of Pediatric Biochemistry · doi:10.3233/jpb-120067 · Cited by 7
Sandhu, A., Rawat, K., Gautam, V., Bhatia, A., Grover, S., Saini, L. K., & Saha, L. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173721 · Cited by 7
Increased Vulnerability to Oxidative Stress and Mitochondrial Dysfunction in Autism
Chauhan, A., & Chauhan, V. P. S. (2015) · Contemporary clinical neuroscience · doi:10.1007/978-1-4939-2190-4_20 · Cited by 7
Self-citationChauhan, V. P. S., & Chauhan, A. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-0440-2_4 · Cited by 7
Self-citationKetogenic diet, adenosine, and dopamine in addiction and psychiatry
Ruskin, D. N., Martinez, L. A., & Masino, S. A. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1492306 · Cited by 6
Zhang, X., Xue, H., Zhu, C., Ji, C., Li, Y. M., & Liu, W. T. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1829127 · Cited by 6
SETD5 haploinsufficiency affects mitochondrial compartment in neural cells
Zaghi, M., Longo, F., Massimino, L., Rubio, A., Bido, S., Mazzara, P. G., Bellini, E. N., Banfi, F., Podini, P., Maltecca, F., et al. (2023) · Molecular Autism · doi:10.1186/s13229-023-00550-9 · Cited by 6
Shao, W., Su, Y., Liu, J., Liu, Y., Zhao, J., & Fan, X. (2024) · Diabetes & Metabolism · doi:10.1016/j.diabet.2024.101543 · Cited by 6
Zink, A., Priller, J., & Prigione, A. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.02.005 · Cited by 6
Oxidative Stress and Mitochondrial Dysfunction in ASDs
Gu, F., Chauhan, V. P. S., & Chauhan, A. (2014) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814602167_0016 · Cited by 6
Self-citationGasser, B. A., Kurz, J., Dick, B., & Mohaupt, M. G. (2022) · Life · doi:10.3390/life12060867 · Cited by 5
The neuroprotective effect of Diosgenin in the rat Valproic acid model of autism
naghdi, M. R., Ahadi, R., Nezhad, A. M., Tabatabaei, F. S. A., Soleimani, M., & Hajisoltani, R. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148963 · Cited by 5
Shielding Effect of Ryanodine Receptor Modulator in Rat Model of Autism
Kumar, H., Kulkarni, G. T., Diwan, V., & Sharma, B. (2021) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.2021.2966.1 · Cited by 5
Mitochondria at the Nanoscale: Physics Meets Biology—What Does It Mean for Medicine?
Mourokh, L. G., & Friedman, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052835 · Cited by 5
Shekhar, N., & Thakur, A. K. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105767 · Cited by 4
Mitochondrial Dysfunction in Autism Spectrum Disorders
Nunes, T., Latini, A., & Gaspar, J. M. (2023) · Springer eBooks · doi:10.1007/978-3-031-42383-3_5 · Cited by 4
Rojas, V., Carrasco‐Gallardo, C., Tenorio, L., Olesen, M. A., Tapia, V., Carrasco, M., Araos, P. A., Quintanilla, R. A., & Ruíz, L. M. (2024) · Autism Research · doi:10.1002/aur.3277 · Cited by 4
Remediate Effect of Ryanodine Receptor Antagonist in Valproic-Acid Induced Autism
Kumar, H., Diwan, V., & Sharma, B. (2022) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2343 · Cited by 4
Varma, M., Bhandari, R., & Kuhad, A. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01247-x · Cited by 4
Frontal and occipital brain glutathione levels are unchanged in autistic adults
Pereira, A. C., Leonard, A., Velthuis, H., Wong, N. M. L., Ponteduro, F. M., Dimitrov, M., Ellis, C. L., Kowalewski, Ł., Lythgoe, D. J., Rotaru, D., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0308792 · Cited by 4
The molecular basis of cognitive deficits in pervasive developmental disorders: Table 1.Preprint
Bhattacharya, A., & Klann, E. (2012) · Learning & Memory · doi:10.1101/lm.025007.111 · Cited by 4
Oxytocin enhances oligodendrocyte development and improves social deficits in autistic rats
Wen, M., Zheng, S., Luo, H., Zhang, Y., & Zhou, B. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1624932 · Cited by 3
Choroid plexus alterations in autism spectrum disorder: A PET-MRI study
Lila, Y., Tseng, C.-E. J., Johnston, E. G., Canales, C., McDougle, C. J., Hooker, J. M., & Zürcher, N. R. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106110 · Cited by 3
Shaban, A. M., Ameen, O., Omar, M., Derbaly, S. A. E., Omara, H. R., Bayomi, A. I., Latif, A. A. A., Elakabawy, Z. I., & Khodir, S. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-09089-6 · Cited by 6
Role of oxidative stress in the pathogenesis of autism spectrum disorders
Belokoskova, S. G., & Tsikunov, S. G. (2023) · Reviews on Clinical Pharmacology and Drug Therapy · doi:10.17816/rcf567781 · Cited by 5
Smith, M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-4788-7_102 · Cited by 3
Sun, Q., Huang, X., Long, H., Guo, J., Zhang, R., Daru, L., Yao, H., Jiang, K., & ., Y. P. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100911 · Cited by 2
Deletion of Mex3c gene leads to autistic-like behavior in mice by inhibiting AMPK signal pathway
Cai, H., Zhang, C., Zhang, H., Du, Y., & Wang, K. (2025) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2025.1551440 · Cited by 2
Pretorius, L., Coetzee, J. A., dos Santos, A. P., & Smith, C. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01232-3 · Cited by 3
Hyperbaric Oxygen Treatment in Autism Spectrum Disorders
Rossignol, D. A. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-0440-2_27 · Cited by 2
Metadata
- Authors
- Chauhan, A., Gu, F., Essa, M. M., Wegiel, J., Kaur, K., Brown, W. T., & Chauhan, V.
- Affiliations
- New York State Office for People With Developmental Disabilities (US)
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2011-02-24
- Volume
- 117
- Issue
- 2
- Pages
- 209-220
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- PMC
- PMC4839269
- OpenAlex
- W1577847097
- Cited by
- 243
- References
- 88
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 26 · 2023: 23 · 2022: 19 · 2021: 17 · 2020: 15 · 2019: 6 · 2018: 17 · 2017: 8 · 2016: 11 · 2015: 18 · 2014: 18 · 2013: 19 · 2012: 21
- FWCI
- 9.90
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Defense
- Office for People With Developmental Disabilities
- National Institute on Aging (P30AG008051)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- autism spectrum disorder, cerebellum, frontal cortex, temporal cortex, oxidative stress, lipid hydroperoxides, brain energy metabolism, children versus adults
- MeSH terms
- Adolescent, Adult, Age Factors, Autistic Disorder, Brain, Child, Child, Preschool, Female, Humans, Lipid Peroxides, Male, Multienzyme Complexes, Postmortem Changes, Case-Control Studies, Reactive Oxygen Species, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review